Tate Charles, Demashkieh Luay, Hakmeh Wael
Emergency Medicine, Chicago Medical School at Rosalind Franklin University of Medicine and Science, North Chicago, USA.
Emergency Medicine, St. George's University School of Medicine, Grenada, GRD.
Cureus. 2021 Jul 28;13(7):e16706. doi: 10.7759/cureus.16706. eCollection 2021 Jul.
A 29-year-old woman presented to the emergency department with palpitations and a heart rate of over 140 beats per minute that started approximately six to eight hours after administration of her second COVID-19 vaccination. Many side effects have been associated with the administration of vaccines. We present the first documented case of tachycardia and palpitations, in the absence of other signs or symptoms, presenting within hours of receiving the Pfizer-BioNTech COVID-19 vaccination. Clinicians should be aware that this appears to be benign and resolved within 24 hours in our patient.
一名29岁女性因心悸前往急诊科,其心率超过每分钟140次,在接种第二剂新冠疫苗后约6至8小时开始出现症状。疫苗接种已出现许多副作用。我们报告了首例有记录的在接种辉瑞-生物科技公司新冠疫苗数小时内出现心动过速和心悸且无其他体征或症状的病例。临床医生应注意,在我们的患者中,这种情况似乎是良性的,且在24小时内得到缓解。